![Salvatore Giovine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Salvatore Giovine worked as a Senior Finance Director at Johnson & Johnson from 2006 to 2021.
He then worked as the Chief Financial Officer at Xilio Therapeutics, Inc. from 2021 to 2022.
Mr. Giovine received his undergraduate and MBA degrees from Gabelli School of Business.
Eerdere bekende functies van Salvatore Giovine
| Bedrijven | Functie | Einde |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Financieel Directeur/CFO | 19-08-2022 |
| JOHNSON & JOHNSON | Financieel Directeur/CFO | 01-03-2021 |
Opleiding van Salvatore Giovine
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
95
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Gabelli School of Business
 Gabelli School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
